Long-term trends in intraocular pressure after combined vitrectomy with sub-tenon injection of triamcinolone acetonide

Retina. 2015 Mar;35(3):564-9. doi: 10.1097/IAE.0000000000000333.

Abstract

Purpose: To evaluate the long-term effect of vitrectomy by itself and combined vitrectomy with sub-Tenon injection of triamcinolone acetonide (TA) on intraocular pressure (IOP).

Methods: In a retrospective cohort study, the medical records of 56 eyes of 56 patients who underwent nonemergent vitrectomy and were followed up for at least 24 months were reviewed. Thirty-two eyes of 32 patients underwent combined vitrectomy with sub-Tenon injection of TA. Twenty-four eyes of 24 patients underwent vitrectomy only. Increased IOP of >4 mmHg from the baseline, change in IOP from the baseline, and preoperative and postoperative measured IOPs were recorded and compared between the two groups, and with fellow eyes.

Results: Minimum follow-up period was 24 months. Except the IOP at postoperative 1 day, there were no significant differences between vitrectomized eyes and nonvitrectomized fellow eyes. There were also no differences between vitrectomized eyes and eyes that underwent combined vitrectomy with sub-Tenon injection of TA. And in the comparison of the vitrectomy-only eye group and the vitrectomy with sub-Tenon TA eye group, there was also no significant difference during the whole follow-up period.

Conclusion: Vitrectomy by itself or combined vitrectomy with sub-Tenon injection of TA does not seem to increase IOP in the long term.

MeSH terms

  • Aged
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Glucocorticoids / therapeutic use*
  • Humans
  • Injections, Intraocular
  • Intraocular Pressure / physiology*
  • Male
  • Middle Aged
  • Retinal Diseases / surgery
  • Retrospective Studies
  • Tenon Capsule / drug effects*
  • Tonometry, Ocular
  • Triamcinolone Acetonide / therapeutic use*
  • Vitrectomy*
  • Vitreous Hemorrhage / surgery

Substances

  • Glucocorticoids
  • Triamcinolone Acetonide